Condensed Consolidated Statement of Comprehensive Income

Continuing operations

Revenue from contracts with customers

(5.6)

3 485 438

3 693 642

7 303 235

Dividends received

180

143

143

Finance income

28 414

17 017

54 961

Other income

1

17

50

Profit on disposal of subsidiary**

–

5 101

5 101

Insurance revenue

74 349

67 705

143 605

Insurance service expense

(70 273)

(60 719)

(138 995)

Insurance finance income

3 545

3 557

7 484

Cost of pharmaceutical products and finished goods

36.7

(307 282)

(485 172)

(804 162)

Cost of distribution of pharmaceutical products

(31 067)

(29 811)

(57 253)

Employee benefit costs

(7.6)

(1 497 050)

(1 391 576)

(2 795 469)

Other expenses

(282 545)

(384 880)

(892 564)

Capitation funds

(3.7)

(825 224)

(856 684)

(1 661 136)

Amortisation

1

(21.3)

(83 233)

(105 730)

(202 081)

Rent and property costs

(64 832)

(60 101)

(130 625)

Right-of-use asset depreciation

(27 532)

(31 444)

(60 090)

Depreciation

(59 463)

(62 247)

(123 999)

IT costs

(201 471)

(196 600)

(285 432)

Reversal of impairment of property and equipment

1

–

–

Impairment of goodwill

–

–

(810 935)

Impairment of right-of-use asset

–

–

(1 498)

Impairment of intangible assets

–

–

(11 180)

Impairment of property and equipment

–

–

(1 301)

Reversal of impairment of loans

–

33

–

Fair value losses

–

–

(919)

Share of profits from associates and joint ventures

1 285

2 600

6 663

Interest on lease liabilities

(4 904)

(7 205)

(13 273)

Finance costs

(26 894)

(29 155)

(62 231)

Income tax expense

(27 729)

(39 620)

(114 046)

Owners of the parent

78 762

39 281

(660 931)

Non-controlling interests

4 952

9 590

14 984

Discontinued Operations

(Loss)/profit from discontinued operations net of tax

6

(12 920)

57 783

(613 279)

Profit/(loss) for the period attributable to:

Owners of the parent

65 842

97 064

(1 274 210)

Non-controlling interests

4 952

9 590

14 984

Other comprehensive income/(loss)

Components of other comprehensive income/(loss) that will not be reclassified to profit or loss

Total other comprehensive loss that will not be reclassified to profit or loss

–

–

(188)

Remeasurement of post-employment benefit obligations

Income tax relating to these items

Components of other comprehensive income/(loss) that will be reclassified to profit or loss

Foreign exchange income/(loss) from continuing operations

Comprehensive income/(loss) attributable to:

Comprehensive income/(loss) attributable to owners of the parent

72 112

91 509

(1 285 096)

Comprehensive income attributable to non-controlling interests

4 952

9 590

14 984